Zusammenfassung
As soon as the diagnosis of a metabolic disorder is suspected, a plan for its emergency management should be made. This chapter focuses on the main clinical presentations in neonates, children and adults with those inborn errors of metabolism for which emergency treatment may be life saving and outlines the first steps of such treatment up to when the exact diagnosis is known.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bodamer OA, Hoffmann GF, Visser GH et al. (1997) Assessment of energy expenditure in metabolic disorders (review). Eur J Pediatr 156:S24–28
Feillet F, Bodamer OA, Dixon MA, Sequeira S, Leonard JV (2000) Resting energy expenditure in disorders of propionate metabolism. J Pediatr 136:659–663
Nyhan WL, Rice-Kelts M, Klein J, Barshop BA (1998) Treatment of the acute crisis in maple syrup urine disease. Arch PediatrAdolesc Med 152:593–598
Wendel U, Langenbeck U, Lombeck I, Bremer HJ (1982) Maple syrup urine disease – therapeutic use of insulin in catabolic states. Eur J Pediatr 139:172–175
Picca S, Bartuli A, Dionisi-Vici C (2008) Medical management and dialysis therapy for the infant with an inborn error of metabolism. Semin Nephrol 28:477–480
Picca S, Dionisi-Vici C, Abeni D et al. (2001) Extracorporeal dialysis in neonatal hyperammonaemia: modalities and prognostic indicators. Pediatr Nephrol 16:862–867
Ogier de Baulny H (2002) Management and emergency treatments of neonates with a suspicion of an inborn error of metabolism. Semin Neonatol 7:17–26
Prietsch V, Lindner M, Zschocke J, Nyhan WL, Hoffmann GF (2002) Emergency management of inherited metabolic diseases. J Inherit Metab Dis 25:531–546
Ogier de Baulny H, Benoist JF, Rigal O et al. (2005) Methylmalonic and propionic acidaemias: management and outcome. J Inherit Metab Dis 28:415–423
Brusilow SW, Maestri NE (1996) Urea cycle disorders: diagnosis, physiopathology, and therapy. Adv Pediatr 43:127–170
Enns GM, Berry SA, Berry GT et al. (2007) Survival after treatment with phenylacetate and benzoate for urea-cycle disorders. N Engl J Med 356:2282–2292
Walter JH, Wraith JE, Cleary MA (1995) Absence of acidosis in the initial presentation of propionic acidaemia. Arch Dis Child Fetal Neonatal Ed 72:F197–199
Häberle J, Boddaert N, Burlina A et al. (2012) Suggested guidelines for the diagnosis and management of urea cycle disorders. Orphanet J Rare Dis 29:32
Dave P, Curless R, Steinman L (1984) Cerebellar hemorrhage complicating methylmalonic and propionic acidemia. Arch Neurol 41:1293–1296
Surtees R, Leonard JV (1989) Acute metabolic encephalopathy: a review of causes, mechanisms and treatment. J Inherit Metab Dis 12:42–54
Orban T, Mpofu C, Blackensee D (1994) Severe CNS bleeding followed by a good clinical outcome in the acute neonatal form of isovaleric aciduria. J Inherit Metab Dis 17:755–756
Berry GT, Heidenreich R, Kaplan P et al. (1991) Branched-chain amino acid-free parenteral nutrition in the treatment of acute metabolic decompensation in patients with maple syrup urine disease. N Engl J Med 324:175–179
Khaler SG, Millington DS, Cederbaum SD et al. (1989) Parenteral nutrition in propionic and methylmalonicacidemia. J Pediatr 115:235–241
Servais A, Arnoux JB, Lamy C et al. (2013) Treatment of acute decompensation of maple syrup urine disease in adult patients with a new parenteral amino-acid mixture. J Inherit Metab Dis 36:939–944
Parini R, Sereni LP, Bagozzi DC et al. (1993) Nasogastric drip feeding as the only treatment of neonatal maple syrup urine disease. Pediatrics 92:280–283
Touati G, Valayannopoulos V, Mention K et al. (2006) Methylmalonic and propionic acidurias: management without or with a few supplements of specific amino acid mixtures. J Inherit Metab Dis 29:288–299
Thompson GN, Francis DE, Halliday D (1991) Acute illness in maple syrup urine disease: dynamics of protein metabolism and implications for management. J Pediatr 119:35–41
Ruch T, Kerr D (1982) Decreased essential aminoacid requirements without catabolism in phenylketonuria and maple syrup urine disease. Am J Clin Nutr 35:217–228
Biggemann B, Zass R, Wendel U (1993) Postoperative metabolic decompensation in maple syrup urine disease is completely prevented by insulin. J Inherit Metab Dis 16: 912–913
Leonard JV, Umpleby AM, Naughten EM, Boroujerdy MA, Sonksen PH (1983) Leucine turnover in maple syrup urine disease. J Inherit Metab Dis 6:S117–118
Feillet F, Leonard JV (1998) Alternative pathway therapy for urea cycle disorders (review). J Inherit Metab Dis 21:S101–111
Griffith AD, Cyr DM, Egan SG, Tremblay GC (1989) Inhibition of pyruvate carboxylase by sequestration of coenzyme A with sodium benzoate. Arch Biochem Biophys 269:201–207
Kalbag SS, Palekar AG (1988) Sodium benzoate inhibits fatty acid oxidation in rat liver: effect on ammonia levels. Biochem Med Metab Biol 40:133–142
Petrowski S, Nyhan WL, Reznik V et al. (1987) Pharmacologic amino acid acylation in the acute hyperammonemia of propionic acidemia. J Neurogenet 4:87–96
Baumgartner MR, Hörster F, Dionisi-Vici C et al. (2014) Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia. Orphanet J Rare Dis 9:130
Filipowicz HR, Ernst SL, Ashurst CL, Pasquali M, Longo N (2006) Metabolic changes associated with hyperammonemia in patients with propionic acidemia. Mol Genet Metab 88:123–130
Kölker S, Cazorla AG, Valayannopoulos V et al. (2015) The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation. J Inherit Metab 38:1041–57
Gebhardt B, Vlaho S, Fischer D et al. (2003) N-Carbamoylglutamate enhances ammonia detoxification in a patient with decompensated methylmalonic aciduria. Mol Genet Metab 79:303–304
Filippi L, Gozzini E, Fiorini P et al. (2010) N-carbamylglutamate in emergency management of hyperammonemia in neonatal acute onset propionic and methylmalonic aciduria. Neonatology 97:286–90
Lévesque S, Lambert M, Karalis A et al. (2012) Short-term outcome of propionic aciduria treated at presentation with N-carbamylglutamate: a retrospective review of four patients. JIMD Rep 2:97–102
Chalmers RA, Roe CR, Stacey TE, Hoppel CL (1984) Urinary excretion of l-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: evidence for secondary insufficiency of l-carnitine. Pediatr Res 18:1325–1328
Roe CR, Millington DS, Maltby DA, Bohan TP, Hoppel CL (1984) L-Carnitine enhances excretion of propionyl coenzyme A as propionylcarnitine in propionic acidemia. J Clin Invest 73:1785–1788
Matern D, Seydewitz HH, Lehnert W et al. (1996) Primary treatment of propionic acidemia complicated by acute thiamine deficiency. J Pediatr 129:758–760
Mayatepek E, Schulze A (1999) Metabolic decompensation and lactic acidosis in propionic acidaemia complicated by thiamine deficiency. J Inherit Metab Dis 22:189–190
Roe CR, Millington DS, Maltby DA, Kahler SG, Bohan TP (1984) L- Carnitine therapy in isovalericacidemia. J Clin Invest 74:2290–2295
Schaefer F, Straube E, Oh J, Mehls O, Mayatepek E (1999) Dialysis in neonates with inborn errors of metabolism. Nephrol Dial Transplant 14:910–918
Jouvet P, Poggi F, Rabier D et al. (1997) Continuous venovenoushaemodiafiltration in the acute phase of neonatal maple syrup urine disease. J Inherit Metab Dis 20:463–472
Rutledge SL, Havens PL, Haymond MW et al. (1990) Neonatal hemodialysis: effective therapy for the encephalopathy of inborn errors of metabolism. J Pediatr 116:125–128
Ring E, Zobel G, Stoeckler S (1990) Clearance of toxic metabolites during therapy for inborn errors of metabolism. J Pediatr 117:349–350
Falk MC, Knight JF, Roy LP et al. (1994) Continuous venovenoushaemofiltration in the acute treatment of inborn errors of metabolism. Pediatr Nephrol 8:330–333
Thompson GN, Butt WW, Shann FA et al. (1991) Continuous venovenous hemofiltration in the management of acute decompensation in inborn errors of metabolism. J Pediatr 118:879–884
Summar M, Pietsch J, Deshpande J, Schulman G (1996) Effective hemodialysis and hemofiltration driven by an extracorporeal membrane oxygenation pump in infants with hyperammonemia. J Pediatr 128:379–382
Picca S, Dionisi-Vici C, Bartuli A et al. (2015) Short-term survival of hyperammonemic neonates treated with dialysis. Pediatr Nephrol 30:839–47
Goertner L, Leupold D, Pohlandt F, Bartmann P (1989) Peritoneal dialysis in the treatment of metabolic crises caused by inherited disorders of organic and amino acid metabolism. Acta Pediatr Scand 78:706–711
Pela I, Seracini D, Donati MA et al. (2008) Peritoneal dialysis in neonates with inborn errors of metabolism: is it really out of date? Pediatr Nephrol 23:163–168
Alexander SR (1990) Continuous arteriovenous hemofiltration. In: Levin DL, Morris FC (eds) Essentials of pediatric intensive care. Quality Medical, St Louis, Mo, pp 1022–1048
Gouyon JB, Desgres J, Mousson C (1994) Removal of branched-chain amino acids by peritoneal dialysis, continuous arteriovenous hemofiltration, and continuous arteriovenous hemodialysis in rabbits: implications for maple syrup urine disease treatment. Pediatr Res 35:357–361
Casadevall I, Ogier H, Germain JF et al. (1992) Hémofiltration artérioveineuse continue: prise en charge d’un cas de leucinose néonatale. Arch Fr Pediatr 49:803–805
Sperl W, Geiger R, Maurer H et al. (1992) Continuous arteriovenous haemofiltration in a neonate with hyperammonaemic coma due to citrullinemia. J Inherit Metab Dis 15:158–159
Wiegand C, Thompson T, Bock GH, Mathis RK (1980) The management of life-threatening hyperammonemia: a comparison of several therapeutic modalities. J Pediatr 96:142–144
Barkaoui E, Debray D, Habès D, Ogier H, Bernard O (1999) Favorable outcome of treatment with NTBC of acute liver insufficiency disclosing hereditary tyrosinemia type I. Arch Pediatr 6:540–544
Nobili V, Jenkner A, Francalanci P, Castellano A et al. (2010) Tyrosinemia type 1: metastatic hepatoblastoma with a favorable outcome. Pediatrics 126:e235–e238
Lebigot E, Brassier A, Zater M et al. (2015) Fructose 1,6-bisphosphatase deficiency: clinical, biochemical and genetic features in French patients. J Inherit Metab Dis 38:881–887
Stacpoole PW, Barnes CL, Hurbanis MD, Cannon SL, Kerr DS (1997) Treatment of congenital lactic acidosis with dichloroacetate. Curr Top Arch Dis Child 77:535–541
Abdelmalak M, Lew A, Ramezani R et al. (2013) Long-term safety of dichloroacetate in congenital lactic acidosis. Mol Genet Metab 109:139–143
Mochel F, de Lonlay P, Touati G et al. (2005) Pyruvate carboxylase deficiency: clinical and biochemical response to anaplerotic diet therapy. Mol Genet Metab 84:305–312
Magner M, Dvorakova V, Tesarova M et al. (2015) TMEM70 deficiency: long-term outcome of 48 patients. J Inherit Metab Dis 38:417–426
Schmitt B, Baumgartner M, Mills PB et al. (2010) Seizures and paroxysmal events: symptoms pointing to the diagnosis of pyridoxine-dependent epilepsy and pyridoxine phosphate oxidase deficiency. Dev Med Child Neurol 52:e133–e142
Gallagher RC, Hove v JL, Scharer G et al. (2009) Folinic acid-responsive seizures are identical to pyridoxine-dependent epilepsy. Ann Neurol 65:550–556
MacDonald A, Dixon M, White F (2008) Disorders of amino acid metabolism, organic acidemias and urea cycle defects. In: Shaw V, Lawson M (eds) Clinical paediatric dietetics, 3rd edn. Blackwell, Oxford, UK, chap 17
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schiff, M., Mochel, F., Dionisi-Vici, C. (2016). Emergency Treatments. In: Saudubray, JM., Baumgartner, M., Walter, J. (eds) Inborn Metabolic Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-49771-5_4
Download citation
DOI: https://doi.org/10.1007/978-3-662-49771-5_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-49769-2
Online ISBN: 978-3-662-49771-5
eBook Packages: MedicineMedicine (R0)